ERBB2 and neoplasm: Aberrant splicing of genomic loci, including those encoding estrogen receptors (ERs), HER2/neu, Cyclin D1, BRCA1, BARD1, Tenscin-C, and CD44, has been implicated in breast carcinogenesis [69].